Tag Archives: immune system

GSK and University of Oxford Launch Cancer Prevention Research Program with £50 Million Investment

(IN BRIEF) GSK and the University of Oxford have launched the GSK-Oxford Cancer Immuno-Prevention Programme, a new research initiative focused on cancer prevention through vaccination. GSK is investing up to £50 million to explore how precancerous cells develop into cancer, … Read the full press release

New Breakthrough in Pancreatic Cancer Treatment Developed by University of Copenhagen Researchers

(IN BRIEF) Researchers from the University of Copenhagen and Rigshospitalet have made significant strides in developing a new treatment for pancreatic cancer using antibody-drug conjugates (ADCs). This targeted therapy promises to improve survival rates by precisely attacking cancer cells while … Read the full press release

Circularity: Alfa Laval membrane filtration systems to turn crop leftovers into prebiotic dietary fibre for a Danish food facility

(PRESS RELEASE) LUND, 24-Jan-2022 — /EuropaWire/ — Alfa Laval, a world leader in heat transfer, centrifugal separation and fluid handling, has announced it will supply membrane filtration systems to a food facility in Denmark for the production of healthy dietary … Read the full press release

NWO announces Industrial Partnership Programme grant for research on better nutrition for our intestinal bacteria

(PRESS RELEASE) THE HAGUE, 2-Apr-2020 — /EuropaWire/ — A consortium led by Paul de Vos (University Medical Center Groningen) will undertake a research into better nutrition for our intestinal bacteria. The project is within the Industrial Partnership Programme (IPP). This … Read the full press release

New Study Shows Immune System Can Spot Changes in Identity of Cancer Antigens

BIRMINGHAM, 19-Apr-2017 — /EuropaWire/ — A new study has identified novel mechanisms whereby T cells may be able to distinguish an emerging class of targets specifically increased on cancer cells. The study, carried out by researchers from the University of Birmingham … Read the full press release

AstraZeneca’s global biologics research and development arm MedImmune completed its acquisition of US-based Amplimmune for $225M plus $275M based on predetermined milestones

London, United Kingdom, 10-10-2013 — /EuropaWire/ — AstraZeneca today announced that on 4 October MedImmune, its global biologics research and development arm, completed its acquisition of Amplimmune, a privately-held, US-based biologics company focused on developing novel therapeutics in cancer immunology. As previously announced, … Read the full press release

Swedish Karolinska Institutet researchers identified new stabilizing agent of atherosclerotic plaques

06-8-2013 — /EuropaWire/ — Researchers at Karolinska Institutet in Sweden have identified a new stabilizing agent of atherosclerotic plaques. These findings have been published in Science Translational Medicine, and show how the immune system can improve the condition in blood vessels … Read the full press release